FDA Inspection 1114727 — Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd.
The FDA completed an inspection of Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd. on November 7, 2019 in Hubli. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 7, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hubli (India)
Additional Details
Clinical BA/BE